Similar companies
Income Statement (USD)
Q2 '25 | QoQ | |
---|---|---|
Revenue | 192M | 20.4% |
Gross Profit | 146M | 21.9% |
Cost of Revenue | 46M | 15.8% |
Operating expense | 106M | 2.2% |
Net Income | 51M | 61% |
EBITDA | 41M | 231.7% |
Balance Sheet (USD)
Q2 '25 | QoQ | |
---|---|---|
Total Assets | 1.27B | 13.3% |
Total Liabilities | 136M | 69.3% |
Total Equity | 1.14B | 9% |
Shares Outstanding | 178M | 0% |
Cash Flow (USD)
Q2 '25 | QoQ | |
---|---|---|
Cash from operations | 135M | 1188.7% |
Cash from investing | -64M | 1516.6% |
Cash from financing | 4.7M | 1127.2% |
EPS
Financial Highlights for Astera Labs in Q2 '25
Astera Labs reported a revenue of 192M, which is a 20.4% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 146M, marking a 21.9% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 46M, a 15.8% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 106M, showing a -2.2% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 51M, showing a 61% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 41M, showing a 231.7% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for Astera Labs with growth in revenue, gross profit, and net income.